MIRA INFORM REPORT

 

 

Report Date :           

02.04.2012

 

IDENTIFICATION DETAILS

 

Name :

MUNAWAR PHARMA (PRIVATE) LIMITED

 

 

Registered Office :

224-A, New Muslim Town, Lahore

 

 

Country :

Pakistan

 

 

Year of Establishment :

1992

 

 

Com. Reg. No.:

00005622

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture & Marketing of Pharmaceutical Products

 

 

No. of Employees :

155

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Pakistan          

b2

b2

           

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Business Name

 

MUNAWAR PHARMA (PRIVATE) LIMITED

 

 

Full Address

 

Registered Address

224-A, New Muslim Town, Lahore, Pakistan

                       

Tel #

92 (42) 35841327, 35841328

Fax #

92 (42) 35841328

Email

mpharm@wol.net.pk

 

Note:

 

The Registered Address of the company has been changed from “24,Circular Road, Outside Lahori Gate, Lahore” to “224-A, New             Muslim Town, Lahore, Pakistan”.

 

 

Factory Location

 

Address

31 KM, Ferozepur Road, Lahore, Pakistan

Tel #

92 (42) 35270973, 35270974

Fax #

92 (42) 35272566

 

 

 

Short Description of Business

 

a.

Nature of Business        

Manufacture & Marketing of Pharmaceutical Products

b.

Year Established

1992

c.

Registration #

00005622

 

 

Auditors

 

Aslam Khan & Co.

(Chartered Accountants)

11-Happy Home, 38/A Main Gulberg, Salman Ahmad Road, Lahore, Pakistan

 

 

Legal Status       

 

Subject Company was established as a Private Limited Company in 1992

 

 

Authorized Capital

Rs. 40,000,000/- Divided into 400,000 shares of Rs.100/- each

Issued & Paid up Capital

Rs. 15,300,000/- Divided into 153,000 shares of Rs. 100/- each

 

 

Details of Directors    

 

Names

Nationality

Address

Designation

Mr. Mohammad Arshad Sheikh

 

 

Mr. Sheikh Muhammad Rafi

 

 

Mr. Javed Iqbal Sheikh

 

 

 

Mr. Imran Arshad

 

 

 

Mr. Naveed Ahmad

 

 

 

Mr. Adnan Arshad

 

 

 

Mr. Muhammad Waqas

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

H. No. 3 Gulam Nabi Colony, Samanabad, Lahore

 

H. No.2 Gulam Nabi Colony, Samanabad, Lahore

 

H. No. 51-S, 22-B/3, Jinnah Colony, Samanabad, Lahore

 

H. No. 51-S, 22 B/3, Jinnah Colny, Samanabad, Lahore

 

H. No. 3 Gulam Nabi Colony, Samanabad, Lahore

 

H. No. 3 Gulam Nabi Colony, Samanabad, Lahore

 

H. No. 3 Gulam Nabi Colony, Samanabad, Lahore

Chief

Executive

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

  

 

Shareholders

 

Names

No of Shares

Waheed Ahmad

 

 

Sheikh Mohammed Rafi

 

 

Javaid Iqbal Sheikh

 

 

Muhammad Usman

 

 

Muhammad Waqas

 

 

Mst. Haleema Javaid

 

 

Imran Arshad

 

 

Naveed Ahmad

 

 

Wasim Ahmad

 

 

Mr. Mohammad Arshad Sheikh

 

 

Adnan Arshad

 

 

Muhammad Yousaf

 

 

Nadeem Ahmed

 

 

Arslan Waheed

 

 

Muhammad Shafique

 

 

Muhammad Shafique

 

10,000

 

 

10,000

 

 

14,000

 

 

5,000

 

 

10,000

 

 

7,000

 

 

10,000

 

 

10,000

 

 

10,000

 

 

12,000

 

 

10,000

 

 

10,000

 

 

10,000

 

 

5,000

 

 

10,000

 

 

10,000

 

Associates      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

A.         Subsidiary

 

                                                        None

 

B.         Associated Companies                       

 

- Do -

 

 

Product/Services

           

Engaged in manufacture and sale of pharmaceutical products by their brand name of AMCOUGH, AMINOPHYLLINE, AMOXYCILLIN, AMPLOX, ANALVON, ASCORBIC ACID, ASPIRIN, CANDICAN, CEFITOL, CEFITOL FORTE, CEPHRIDE, CHLOROQUINE PHOSPHATE, CHLORPHENIRAMINE, CLOCIL FORTE, DEXAMED, DEXAMETHASONE, DIDOMET, DIMEN, DIMENTIN, EMITIN, ERYTHROMYCIN, FOSFOMYCIN, FUMOLIC, GASTROGEL, GLUBIRON, GLUBIRON F, HYLINE, HYOSCINE, HYOSCINE COMPOUND, IBUPROFEN, INDOMETHACIN, LAXIDE, LAXIL, LINCOMED, M-PHENICOL, M. CLOX, MANURAX, MENAMIC, METOCLOP, METRONIDAZOLE, MUANPOL, MUNOQUINE, MZOLE, MZOLIDONE, NAPLUR, OXYTETRACYCLINE, PARACETAMOL, PESPOLIN, PHENAMINE, PHENOBARBITONE, PHOLTUSS,THYRAXINIL, TRISEP, VIBREX, WORMATIN, ZAMID, ZEPOX, ZONATE

 

 

Annual Production Volume        

 

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacture.

 

 

Number of Employees

 

155

 

 

Annual Sales Volume       

           

Year

In Pak Rupees

2010

160,000,000/- (Estimated)

 

Trade Suppliers (Foreign)

 

·         ASHU INTERNATIONAL, INDIA.

·         SHOUGUANG FUKANG PHARMACEUTICAL CO. LTD, CHINA.

·         MANGALAM DRUGS & ORGANICS LIMITED, INDIA.

·         STARWAY PHARMA CO. LIMITED, CHINA.

·         SINOCHEM TIANJIN CORPORATION, CHINA.

·         POLYDRUG LABORATORIES (PVT) LTD, INDIA.

 

 

Bankers

 

The Royal Bank of Scotland, Pakistan.

Habib Bank Limited, Pakistan.

MCB Bank Limited, Pakistan.

Bank Alfalah Limited, Pakistan.

 

 

Foreign Exchange Rates

 

Currency

 

Unit

Pakistani Rupee

US Dollar

1

           Rs. 90.50

UK Pound

1

           Rs. 144.00

Euro

1

           Rs. 120.30

 

 

Memberships

 

·         Lahore Chamber of Commerce & Industry. (LCCI)

·         Pakistan Pharmaceutical Manufacturers Association. (PPMA)

 

 

Comments

 

Subject Company was established in 1992 and is engaged in manufacture & marketing of pharmaceutical products. Trade relations are reported as fair.  Payment to creditors etc are reported as normal. The Company can be considered for normal business dealings at usual trade terms and conditions.

 

 

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.51.16

UK Pound

1

Rs.81.72

Euro

1

Rs.68.34

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.